Clinical trials
Intravenous clinical trials
Below are recruiting intravenous clinical trials, each written for real people, not researchers. We’re tracking 544 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07474909Recruiting
Comparing two ways to give dexamethasone for hand surgery in children
This trial compares giving dexamethasone near the nerves versus through an IV to see which works better for pain relief during hand or forearm surgery in children. It may help your child have a smoother recovery.
PoznanAges 3 months–16 years - NCT07476859RecruitingPhase 4
Iron for heart attack recovery in older adults
This study tests whether giving iron through a vein can improve quality of life in older adults who recently had a heart attack or unstable angina and also have low iron levels. If you qualify, you would receive either iron or a placebo (inactive substance) to see if iron helps you feel better and recover faster.
El Palmar, MurciaAges 65 years+ - NCT07475936Recruiting
Tenecteplase for very old patients with stroke
This trial tests if a clot-busting drug called tenecteplase is safe and effective for people over 80 who have an ischemic stroke and can get treatment within 4.5 hours of symptoms starting.
Nanning, GuangxiAges 80 years+ - NCT03426579Recruiting
Testing sedation monitoring during anesthesia for children’s throat surgery
This trial looks at whether a monitoring method for how deeply a child is sedated matches how the child’s reflexes react during intravenous anesthesia. It may help anesthesiologists keep children safer and more comfortable during direct laryngoscopy procedures using medications like dexmedetomidine and remifentanil.
Edegem, AntwerpAges 1 month–8 years - NCT07466550RecruitingPhase 1
Study of how risankizumab moves through the body in healthy adults
This trial studies how the drug risankizumab moves through your body after being given through a vein or under the skin. It helps doctors understand the best way to give the medicine to patients.
Anaheim, CaliforniaAges 18–65 - NCT07471555Enrolling by invitation
Vascular access and intraosseous study for nursing students
This trial tests a teaching method for inserting a special needle into bone (intraosseous access) and regular IV lines. It is only for 4th year nursing students.
Valencia, ValenciaAges 18 years+ - NCT07466108Recruiting
IV paracetamol during emergency abdominal surgery
This trial tests whether giving paracetamol (Tylenol) through a vein during emergency belly surgery helps keep your blood pressure and heart rate stable. It may be an option for adults who are not critically unstable or have certain serious heart conditions.
Cairo, Cairo GovernorateAges 21–65 - NCT07459413Recruiting
Drinking vs. IV fluids to protect kidneys from contrast dye
This trial compares drinking fluids by mouth versus receiving fluids through an IV to prevent kidney injury from CT contrast dye. It may be a good option if you have mild to moderate kidney disease and need a contrast CT while in the emergency department.
Istanbul, GaziosmanpasaAges 18 years+ - NCT07455565Recruiting
Pain monitoring with ANI after lumbar spine surgery
This study tests a new way to monitor pain after lower back surgery using a device called ANI, which tracks your body's response to pain. The goal is to see if this method helps doctors give you better pain relief.
Antalya, AntalyaAges 18–65 - NCT04140903RecruitingPhase 4
Oral antibiotics after 14 days for bacterial brain abscess
This trial looks at whether continuing treatment for a bacterial brain abscess using partially oral antibiotics works as well as the usual approach. It may help people who have already had 14 days of antibiotic treatment and are stable enough to take medicines by mouth.
AalborgAges 18 years+ - NCT07446023Recruiting
Testing a new way to measure heart artery blockages
This study compares two advanced imaging methods (IVUS and FFR) to see which better identifies blockages that need treatment. It may help doctors decide the best care for people with chest pain or recent heart attacks.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07444788RecruitingPhase 1
Acute effects of 5-MeO-DMT in healthy people
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
Basel, Canton of Basel-CityAges 25–65 - NCT07448155RecruitingPhase 1
Testing a new drug in healthy volunteers
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Tempe, ArizonaAges 18–55 - NCT06804434Recruiting
Pain monitor during stomach or liver cancer surgery
This trial tests a device that monitors your pain level during surgery using a special index called the Nociception Level Index. It may help doctors manage your pain better without using too much medicine.
Cluj-Napoca, ClujAges 18 years+ - NCT06346041RecruitingEarly Phase 1
Testing a new IV drug IDOV-SAFE for advanced solid tumors
This trial tests a new intravenous drug called IDOV-SAFE in people with advanced solid tumors that have stopped responding to standard treatments or have no effective standard option. The goal is to see if it is safe and effective.
BeijingAges 18–75 - NCT07442812Recruiting
Dexamethasone: pill vs. IV for knee replacement recovery
This trial compares two ways of giving dexamethasone (a strong anti-inflammatory) for people having knee replacement surgery. One group gets a pill and the other gets an IV. The goal is to see which method works better for pain, swelling, and recovery.
Istanbul, IstanbulAges 50–80 - NCT06810596Recruiting
Comparing two insulin infusion methods for diabetic ICU adults
This trial compares two ways of giving insulin through an IV to adults with diabetes in the intensive care unit to find which works better for controlling blood sugar.
IsmailiaAges 19 years+ - NCT06718946RecruitingEarly Phase 1
IV IDOV-SAFE for advanced solid tumors: safety and effect study
This trial tests a new drug called IDOV-SAFE given through a vein. It is for people with advanced solid tumors that have not responded to standard treatments. The study aims to see if the drug is safe and if it can help shrink tumors.
ShanghaiAges 18–75 - NCT07434427RecruitingPhase 4
Buprenorphine vs. oxycodone for pain after lung surgery
This study compares two common pain medicines given through a patient-controlled pump after lung surgery done with small incisions. The goal is to see which one works better and has fewer side effects.
Zabrze, Silesian VoivodeshipAges 18–75 - NCT06814223RecruitingPhase 4
Can antibiotics prevent catheter infections in dialysis patients?
This study tests if giving antibiotics before placing a dialysis catheter can prevent infections. It may help people with heart conditions or those who need a catheter in the leg.
Nahariya, IsraelAges 18 years+ - NCT07422207RecruitingPhase 1
Safety study of ME3241 in healthy adults
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
Sydney, New South WalesAges 18–55 - NCT07419997Recruiting
Observational study on clot-busting drugs beyond the usual window
This study looks at patients who received a clot-busting drug (intravenous thrombolysis) for their stroke 4.5 to 24 hours after symptoms started. It aims to see how well this works and what happens to them, using data that has already been collected.
BeijingAges 18 years+ - NCT07409246RecruitingPhase 1
Study of ABBV-438 for multiple myeloma patients
This trial tests a new intravenous treatment, ABBV-438, for adults with multiple myeloma that has returned or not responded to prior therapies. It aims to see if the drug is safe, tolerable, and how it moves through the body.
Duarte, CaliforniaAges 18 years+ - NCT07411599RecruitingPhase 1/Phase 2
CAR-NK cell therapy plus cetuximab for belly-spread colorectal cancer
This trial tests a new cell therapy (CAR-NK cells given directly into your belly and a vein) combined with a targeted drug (cetuximab) for colorectal cancer that has spread mainly to the lining of your belly. It aims to see if this treatment can shrink tumors and help people who have run out of standard chemotherapy options.
Houston, TexasAges 18 years+
Hear when a new Intravenous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for intravenous?
- Yes. Clin2 currently lists 544 recruiting intravenous studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a intravenous trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a intravenous trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.